Pheon Therapeutics
Boston, United States· Est.
Pheon Therapeutics develops antibody-drug conjugates (ADCs) targeting novel cancer antigens.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $68M
About
Pheon Therapeutics develops antibody-drug conjugates (ADCs) targeting novel cancer antigens.
OncologyAntibodies
Funding History
1Total raised:$68M
Series A$68M